Positive results from BioAge muscle atrophy trial
BioAge Labs, Inc. has announced positive phase 1b clinical data for BGE-105, a highly selective,…
December 6, 2022 - 4 minutes
BioAge Labs, Inc. has announced positive phase 1b clinical data for BGE-105, a highly selective,…